Cited by 32Acne and Rosacea Treatments and EffectsDermatology and Skin DiseasesSkin Protection and Aging

A double-blinded, randomized, vehicle-controlled study to access skin tolerability and efficacy of an anti-inflammatory moisturizer in treatment of acne with 0.1% adapalene gel

Chularojanamontri, Leena, Tuchinda, Papapit, Kulthanan, Kanokvalai, Varothai, Supenya, Winayanuwattikun, Waranaree·2016·Journal of Dermatological Treatment

Abstract

INTRODUCTION: Topical retinoids are considered to be the first-line agents and maintenance therapy of acne; however, irritation side effects are major concern issues. Noncomedogenic moisturizers are sometimes added to relieve cutaneous irritations. This study aimed to compare tolerability and efficacy of moisturizers containing licochalcone A, l-carnitine and 1,2-decanediol (active formulation) with a placebo in mild to moderate severe acne in Asian subjects. METHODS: This was an 8-week double-blind, prospective, randomized controlled study. All patients (n = 120) were randomized equally into three groups: (A) adapalene gel, (B) adapalene gel with the active formulation and (C) adapalene gel with the placebo. The severity of acne, skin bioengineering measurements and skin tolerability were recorded during the study. RESULTS: Compared to baseline, the active formulation group showed significant reductions in inflammatory lesions and total lesions at the end of the study without flare-up. Moreover, skin irritations were less detected than in the other two groups by corneometer and transepidermal water loss measurements. CONCLUSIONS: The concomitant usage of adapalene gel and the moisturizer containing licochalcone A, l-carnitine and 1,2-decanediol could reduce undesirable side effects without interfering the efficacy of adapalene. This moisturizer may be superior to placebo to prevent cutaneous irritations and enhance patients' adherence to acne medications.

Integrity signals

Registry

Crossref · 10.3109/09546634.2015.1079298

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • There was a 10.8%-29% mean reduction in TEWL, which was reported to be statistically significant in two studies.

    “Further, there was a 10.8%–29% mean reduction in TEWL, which was reported to be statistically significant in two studies.44, 45, 48, 50, 52, 54”
  • Three lower quality studies reported a decrease in superficial skin oiliness ranging from 17% to 47.3%, and all differences between adjunctive dermocosmetics groups and prescription therapy alone were statistically significant in favour of the adjunctive arms.

    “Three lower quality reported a decrease in superficial skin oiliness ranging from 17% to 47.3%, and all differences between adjunctive dermocosmetics groups and prescription therapy alone were statistically significant in favour of the adjunctive arms.”
  • The RCTs showed a statistically significant improvement in skin hydration on corneometry and a trend towards reducing sebum (sebumeter) with adjunctive dermocosmetics versus prescription therapy alone.

    “As shown in Table 3, the RCTs showed a statistically significant improvement in skin hydration on corneometry and a trend towards reducing sebum (sebumeter) with adjunctive dermocosmetics versus prescription therapy alone.”
  • Benefits included greater reductions in both inflammatory and non-inflammatory lesions, reduced acne flares, maintenance of effects (with continued lesional decreases) after medical therapy was discontinued and a trend towards clinically relevant better global scores.

    “Benefits included greater reductions in both inflammatory and non‐inflammatory lesions, reduced acne flares, maintenance of effects (with continued lesional decreases) after medical therapy was discontinued and a trend towards clinically relevant better global scores.44, 45, 48, 49, 57, 58, 59”

The citation lists haven’t been fetched yet

References 33 · Cited by 32

Authors
Chularojanamontri, L., Tuchinda, P., Kulthanan, K., Varothai, S., & Winayanuwattikun, W.
Affiliations
Siriraj Hospital (TH)
Corresponding author
Tuchinda, Papapit
Venue
Journal of Dermatological Treatment
Published
2015-09-02
Volume
27
Issue
2
Pages
140-145
ISSN
  • 0954-6634 (ISSN-L)
  • 1471-1753
OpenAlex
W1849537629
Cited by
32
References
33
Citations by year
2026: 1 · 2025: 6 · 2024: 2 · 2023: 5 · 2022: 4 · 2021: 4 · 2020: 2 · 2019: 4 · 2018: 2 · 2017: 2
FWCI
1.49
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Dermatological Treatment (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Dermatology › Acne and Rosacea Treatments and Effects
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Health Sciences › Medicine › Dermatology › Skin Protection and Aging
Keywords
acne, adapalene gel, topical retinoids, licochalcone A, L-carnitine, skin tolerability, skin irritation, corneometry, transepidermal water loss, Asian patients, medication adherence
MeSH terms
Adapalene, Acne Vulgaris, Administration, Topical, Adult, Anti-Inflammatory Agents, Dermatologic Agents, Double-Blind Method, Female, Gels, Humans, Male, Prospective Studies, Skin, Chalcones, Medication Adherence, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review